At the molecular level, the PI3K/ AKT pathways contribute to miR-3142-mediated resistance of CML cells, likely mediated by suppressing PTEN expression. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.